| 前收市價 | 24.44 |
| 開市 | 24.55 |
| 買盤 | 24.67 x 600 |
| 賣出價 | 24.72 x 500 |
| 今日波幅 | 24.30 - 24.78 |
| 52 週波幅 | 22.01 - 33.71 |
| 成交量 | |
| 平均成交量 | 2,000,471 |
| 市值 | 4.175B |
| Beta 值 (5 年，每月) | 0.55 |
| 市盈率 (最近 12 個月) | 8.07 |
| 每股盈利 (最近 12 個月) | 3.06 |
| 業績公佈日 | 2024年5月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 35.55 |
Investor's Business DailyThe Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
ZacksDeciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Deciphera Pharmaceuticals (DCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksWill Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
